Hedge Fund Performance Numbers: What to Expect

2010 was a very volatile year and it wasn’t a good year for many hedge funds. We previously reported that Bill Ackman’s Pershing Square is having a phenomenal year, thanks to their General Growth Properties (GGP) investments. Dan Loeb’s Third Point will be returning about 30+% in 2010. Finally Ken Griffin’s Citadel reportedly returned around 10% in 2010. Most other reputable hedge funds performed much worse than these did though. Here’s a quick roundup, winners and losers alike:


Andreas Halvorsen’s Viking Global Equities: Prior to founding Viking Global, Andreas Halvorsen was the director of equities at Julian Robertson’s Tiger Management. This tiger cub is up less than 3% through early December.

Other tiger cubs were also showing similar results in 2010, among them are Shumway Capital Partners’ Chris Shumway, Tiger Asia’s Bill Hwang, and Touradji Capital’s Paul Touradji.

Bill Ackman’s Pershing Square: Pershing Square is up a huge 35.5% through November.

Dan Loeb’s Third Point: Third Point Offshore Fund returned 25.3% through November, whereas Third Point Partners exceeded this with a 32.1% 11-month return.

John Paulson’s Paulson & Co.: Paulson’s Advantage Fund gained a measly 1.8% through November. The fund was down 4.9% in May. According to an investor Paulson’s Advantage Plus Fund (which uses additional leverage) was up 10.2 percent during the first 10 days of December and 14.3 percent for the year. The fund returned 3.7% through November.

Alan Howard’s Brevan Howard: Brevan Howard, based in England, is Europe’s largest hedge fund with nearly $27 billion AUM. During the financial crisis, Brevan Howard’s master fund returned almost 20%. In 2008, the fund returned 20.32% . In 2009, the return was 18.04%. Unfortunately, in 2010 the fund’s 11-month return was only 1.40%.

Louis Bacon’s Moore Global: Louis Bacon’s global macro fund was up 2.5% through November. The fund returned 0.8% in January, -1.9% in February, 3.4% in March, 1% in April, and -9.2% in May.

John Burbank’s Passport Capital: Passport’s Global Strategy fund returned 12.7% during the first 11 months of 2010.

Paul Tudor Jones’ Tudor BVI Global returned 5.4% through early December. Och-Ziff Capital Management’s Master fund advanced 7.6% and D. E. Shaw’s Oculus fund gained more than 6% through November.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!